Research map: Effect of metreleptin treatment in congenital generalized lipodystrophy: a retrospective analysis from the MENA region

Back to the article

Papers in this map

  1. World Medical Association Declaration of Helsinki · 2013 · 30960 citations · Cited by this paper
  2. An advertising poster of “Aama” a poor french acromegalic giantess sold twice! · 2026 · Related
  3. Leptin-Replacement Therapy for Lipodystrophy · Elif A Oral · 2002 · 1244 citations · Cited by this paper
  4. 4-Methylumbelliferone for type 1 diabetes therapy: evidence for β-cell protection via EGFR/PI3K/Akt signaling · 2026 · Related
  5. Acquired and Inherited Lipodystrophies · Abhimanyu Garg · 2004 · 948 citations · Cited by this paper
  6. Determinants of pubertal progression and final height in premature pubarche · 2026 · Related
  7. Lipodystrophies: Genetic and Acquired Body Fat Disorders · Abhimanyu Garg · 2011 · 559 citations · Cited by this paper
  8. Glymphatic dysfunction is associated with hyperglycemia-related cortical thinning in patients with type 2 diabetes mellitus · 2026 · Related
  9. The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline · Rebecca J. Brown · 2016 · 542 citations · Cited by this paper
  10. Beyond monogenic obesity: the unmet need for anti-obesity pharmacotherapy in rare genetic syndromes · 2026 · Related
  11. Clinical Features and Metabolic Derangements in Acquired Generalized Lipodystrophy · Anoop Misra · 2003 · 242 citations · Cited by this paper
  12. Association of C-reactive protein to albumin ratio with progression of CKD and all-cause mortality in diabetic CKD · 2026 · Related
  13. Efficacy and Safety of Leptin-Replacement Therapy and Possible Mechanisms of Leptin Actions in Patients with Generalized Lipodystrophy · Ken Ebihara · 2006 · 232 citations · Cited by this paper
  14. Longitudinal trends in general, central, and visceral adiposity indices among women with endometriosis: a population-based study · 2026 · Related
  15. Diagnosis and treatment of lipodystrophy: a step-by-step approach · David Araújo‐Vilar · 2018 · 203 citations · Cited by this paper
  16. Oral polychemotherapy to induce remission in newly diagnosed type 2 diabetes: results from a randomized controlled trial · 2026 · Related
  17. Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin · Talia Diker‐Cohen · 2015 · 181 citations · Cited by this paper
  18. Phase angle and triglyceride-glucose index as biomarkers of glycemic control, body composition and cardiovascular risk in adolescents with type 1 diabetes: a cross-sectional study · 2026 · Related
  19. Clinical Effects of Long-Term Metreleptin Treatment in Patients With Lipodystrophy · Jean Lin Chan · 2011 · 144 citations · Cited by this paper
  20. Lactobacillus gasseri alleviates type 2 diabetes via modulation of gut microbiota-host metabolic networks · 2026 · Related
  21. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy · Rebecca J. Brown · 2018 · 143 citations · Cited by this paper
  22. Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey · Barış Akıncı · 2016 · 99 citations · Cited by this paper
  23. Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review Study · Barış Akıncı · 2019 · 89 citations · Cited by this paper
  24. Risk Factors for Diabetes in Familial Partial Lipodystrophy, Dunnigan Variety · Wasim A. Haque · 2003 · 79 citations · Cited by this paper
  25. Genetics of Lipodystrophy · Marissa Lightbourne · 2017 · 74 citations · Cited by this paper
  26. Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy · Jean Lin Chan · 2015 · 70 citations · Cited by this paper
  27. Clinical Features and Management of Non-HIV–Related Lipodystrophy in Children: A Systematic Review · Nidhi Gupta · 2016 · 59 citations · Cited by this paper
  28. Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy · Josivan Gomes Lima · 2016 · 57 citations · Cited by this paper
  29. Diagnostic strategies and clinical management of lipodystrophy · Maria Cristina Foss‐Freitas · 2020 · 53 citations · Cited by this paper
  30. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience · David Araújo‐Vilar · 2014 · 50 citations · Cited by this paper
  31. Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network · Héléna Mosbah · 2022 · 41 citations · Cited by this paper
  32. Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy · Fernando Corvillo · 2022 · 38 citations · Cited by this paper
  33. Common Autosomal Recessive Diseases in Oman Derived from a Hospital-Based Registry · Anna Rajab · 2005 · 34 citations · Cited by this paper
  34. Clinical features of generalized lipodystrophy in Turkey: A cohort analysis · İlgın Yıldırım Şimşir · 2023 · 30 citations · Cited by this paper
  35. A rapid action plan to improve diagnosis and management of lipodystrophy syndromes · Lindsay T. Fourman · 2024 · 24 citations · Cited by this paper
  36. Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain · Antía Fernández‐Pombo · 2023 · 23 citations · Cited by this paper
  37. Metabolic and other morbid complications in congenital generalized lipodystrophy type 4 · Gülçin Akıncı · 2024 · 14 citations · Cited by this paper
  38. Genotype-stratified treatment for monogenic insulin resistance: a systematic review · Robert K. Semple · 2023 · 13 citations · Cited by this paper
  39. Effects of Metreleptin in Patients With Generalized Lipodystrophy Before vs After the Onset of Severe Metabolic Disease · Maiah N. Brush · 2024 · 10 citations · Cited by this paper

Source: OpenAlex (CC0)